Kolon Life Science Inc

Kolon Life Science Inc. provides biopharmaceuticals, active pharmaceutical ingredients, pyrithione antimicrobials, and water solutions, primarily in South Korea. Its pipeline includes KLS-1020 (a cancer vaccine), KLS-3021 (an oncolytic viral therapy), and KLS-2031 for neuropathic pain. It also supplies active pharmaceutical ingredients for anti-cancer and intermediates, pyrithione antimicrobials for personal care and industrial uses, and Kolon BESFLOC polymer for various industries and sewage treatment. Formerly Korea Tissuegene Asia, Ltd., it changed its name to Kolon Life Science Inc. in January 2006, was founded in 2000, and is headquartered in Seoul, South Korea.